Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the ...

Fintel reports that on February 27, 2025, Stifel initiated coverage of COMPASS Pathways plc - Depositary Receipt () (NasdaqGS ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...

On Friday, Stifel analysts adjusted their stance on Neumora Therapeutics shares, downgrading the biopharmaceutical company from Buy to Hold. The downgrade comes with a significant reduction in the ...

“We developed Stifel Discover to address our clients’ desire to easily access the firm’s timely and actionable insights as they navigate the complex market landscape. This tool is a powerful ...

On Tuesday, Stifel analysts started coverage on Sionna Therapeutics (NASDAQ:SION) with a positive outlook, assigning the biotech firm a Buy rating and setting a price target of $32.00 - representing a ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass ... announced today that management will present at the Stifel Virtual CNS Forum at 11:30 am ET on March 18 th, 2025. A live audio webcast of the ...

Compass is headquartered in London, UK, with offices in New York and San Francisco in the US. Our vision is a world of mental wellbeing.